Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
---|
03/10/2010 | EP2161291A2 Polymer |
03/10/2010 | EP1951235B1 Novel crystal forms of irinotecan hydrochloride |
03/10/2010 | EP1807420B1 Trisubstituted thiophenes as progesterone receptor modulators |
03/10/2010 | EP1781296B1 Quinazoline derivatives and their use in the treatment of thrombocythemia |
03/10/2010 | EP1682541B1 Method for producing tiotropium salts |
03/10/2010 | EP1511752B3 Camptothecins with a modified lactone ring |
03/10/2010 | EP1445257B1 2h-1-benzopyran compounds for use in a photochromic material |
03/09/2010 | US7674907 2,3-diphenyl-N-((2S)-tetrahydro-2-furanylmethyl)furo[2,3-b]pyridin-4-amine; arthritis, organ transplant, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease, Crohn's disease, lupus, hypersensitivity, type 1 diabetes, psoriasis, dermatitis |
03/09/2010 | US7674803 Thiazolypiperidine derivatives as MTP inhibitors |
03/09/2010 | CA2493313C Novel benzodioxoles |
03/09/2010 | CA2421819C Isoquinolinone potassium channel inhibitors |
03/04/2010 | WO2010025337A1 Method of treating ras associated cancer |
03/04/2010 | US20100056511 2- [ (2-substituted) -ind0lizin-3-yl] -2-oxo-acetamide derivatives as antifungal agents |
03/04/2010 | US20100056503 Compounds for modulating integrin CD11b/CD18 |
03/04/2010 | US20100056498 Substituted monocyclic cgrp receptor antagonists |
03/03/2010 | EP2158206A1 Substituted furopyrimidines and use thereof |
03/03/2010 | EP1885727B1 Syntheses and preparations of narwedine and related novel compounds |
03/03/2010 | CN101659668A Process to prepare camptothecin derivatives and novel intermediate and compounds thereof |
03/03/2010 | CN101659667A Method for purifying irinotecan hydrochloride |
03/02/2010 | US7671190 Transformed host cells that make the anticancer polyketides herbimycin and geldanamycin; biosynthesis |
03/02/2010 | US7671079 Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands |
03/02/2010 | US7671068 N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors |
03/02/2010 | US7671067 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin |
02/25/2010 | WO2010022121A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
02/25/2010 | WO2010021149A1 Spiro compound capable of inhibiting acid secretion |
02/25/2010 | WO2010020548A1 Glyt1 receptor antagonists |
02/25/2010 | WO2008139452A3 Selective bromination of perylene diimides and derivatives thereof under mild conditions |
02/25/2010 | US20100048610 Carbinol derivatives having cyclic linker |
02/25/2010 | US20100048600 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics |
02/25/2010 | US20100048599 Compounds As Kinase Inhibitors |
02/25/2010 | US20100048591 Chemical compounds and processes |
02/25/2010 | US20100048554 Spirocyclic Cyclohexane Compounds |
02/25/2010 | US20100048553 Spirocyclic Cyclohexane Compounds |
02/25/2010 | US20100048551 Tricyclic Compounds Useful as Inhibitors of Kinases |
02/25/2010 | US20100048537 Heteroaryl derivatives |
02/25/2010 | US20100048532 Benzimidazole Derivatives as Selective Acid Pump Inhibitors |
02/25/2010 | US20100048531 GlyT1 RECEPTOR ANTAGONISTS |
02/25/2010 | CA2734486A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
02/24/2010 | EP2155722A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer |
02/24/2010 | CN101657456A pyrano-pyrazole-amines |
02/24/2010 | CN101654456A Water-soluble derivants containing 10-hydroxycamptothecine and preparation method thereof |
02/24/2010 | CN100591680C Dihydrotetrabenazines and pharmaceutical compositions containing same |
02/24/2010 | CN100591676C 2- and 2,5-substituted phenylketo-enols |
02/23/2010 | US7666880 Hydroxamate compounds which are inhibitors of histone deacetylase; may be useful as medicaments for treatment of proliferative disorders as well as other diseases involving, relating to, or associated with enzymes having histone deacetylase activities such as neurodegenerative, cardiovascular disorders |
02/23/2010 | US7666879 enzyme inhibitor; 2-{2-Fluoro-4-[7-(2-methyl-pyridin-4-yl)-imidazo[1,2-a]pyridin-3-yl]-phenyl}-N-(3-trifluoromethyl-phenyl)-acetamide; angiogenesis inhibitor; antitumor agent; treating hyperglycemia, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, autoimmune diseases, inflammation, and eye disorders |
02/23/2010 | US7666869 Nitrogen-containing 5-membered ring compound |
02/18/2010 | WO2009132313A3 Morphinan derivatives of organic and inorganic acids |
02/18/2010 | US20100041900 Isolation of lactam compound from adlay bran and its use on anti-proliferative cancer cells |
02/18/2010 | US20100041690 Co-Administration of Dopamine-Receptor Binding Compounds |
02/18/2010 | US20100041676 Kinase inhibitors |
02/18/2010 | US20100041649 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth |
02/17/2010 | EP2154134A1 Process for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole. |
02/17/2010 | EP1902026B1 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
02/17/2010 | CN101652372A spiro-pyrano-pyrazole derivatives |
02/17/2010 | CN101648950A Tiotropium salts, pharmaceutical composition and uses thereof |
02/17/2010 | CN101648947A 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
02/17/2010 | CN100590124C Tricyclic androgen receptor modulator compounds and method |
02/16/2010 | US7662846 Selective spirocyclic glucocorticoid receptor modulators |
02/16/2010 | US7662833 metalloproteinases inhibitor, particular Peptide Deformylase (Pdf) inhibitor; antibiotic; e.g. 2-(6-fluoro-imidazo[1,2-a]pyridin-3-ylamino)-N-hydroxy-acetamide |
02/16/2010 | US7662832 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
02/16/2010 | US7662818 e.g. 4-[5-(piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; and multiple sclerosis |
02/16/2010 | CA2539985C Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
02/16/2010 | CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors |
02/16/2010 | CA2442882C Sulphones which modulate the action of gamma-secretase |
02/16/2010 | CA2415295C Radioligand and binding assay |
02/16/2010 | CA2406095C Synthetic process for the manufacture of an ecteinaschidin compound |
02/16/2010 | CA2346082C Tricyclic .delta.3-piperidines as pharmaceuticals |
02/16/2010 | CA2341707C Pyrimidine derivatives |
02/11/2010 | WO2010017418A1 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
02/11/2010 | WO2010015985A1 Tricyclic alkylaminomethyloxazolidinone derivatives |
02/11/2010 | WO2009138386A3 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
02/11/2010 | US20100034741 Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor |
02/11/2010 | CA2731365A1 Tricyclic alkylaminomethyloxazolidinone derivatives |
02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
02/10/2010 | CN101646678A Heteroaryl derivative |
02/10/2010 | CN101646677A Process for making asenapine |
02/09/2010 | US7659283 Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases |
02/09/2010 | US7659265 5-(4,4-dimethyl-2-thioxo-1,4-dihydro-2H-3,1-benzoxazin-6-yl)-1-methyl-1H-pyrrole-2-carbothioamide; menopause therapy; contraceptive; anticancer agents |
02/09/2010 | CA2430673C N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization |
02/09/2010 | CA2299754C Hydroxy-substituted n-alkoxy hindered amines |
02/09/2010 | CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |
02/04/2010 | WO2010014930A2 Therapeutic agents |
02/04/2010 | WO2010014516A1 Nitro derivatives of furasemide and their use as diuretics |
02/04/2010 | WO2010012789A1 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds |
02/04/2010 | WO2010012714A1 Nitrogenated derivatives of pancratistatin |
02/04/2010 | WO2010012381A1 Streptospirole derivatives |
02/04/2010 | WO2009001129A9 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors |
02/04/2010 | US20100029953 Phenyltetraene-based nonlinear optical chromophores |
02/04/2010 | US20100029707 Tricyclic compound and medical use thereof |
02/04/2010 | US20100029678 Diuretics |
02/04/2010 | US20100029639 Ion channel modulating compounds and uses thereof |
02/04/2010 | US20100029632 improved pharmacokinetics |
02/04/2010 | US20100029625 Therapeutic Agent for Restenosis |
02/04/2010 | US20100029614 Spirocyclic heterocyclic derivatives and methods of their use |
02/04/2010 | CA2732628A1 Therapeutic agents |
02/04/2010 | CA2731957A1 Nitro derivatives of furasemide and their use as diuretics |
02/04/2010 | CA2731901A1 Nitrogenated derivatives of pancratistatin |
02/04/2010 | CA2731405A1 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds |
02/03/2010 | EP2148882A1 Process for making topotecan |
02/03/2010 | EP2148877A2 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |